REQUEST A DEMO
Total
USD $0.00
Search more companies

Agtc Genomics Sdn. Bhd. (Malaysia)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology) | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Medical Laboratories
Full name: Agtc Genomics Sdn. Bhd. Profile Updated: February 26, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Agtc Genomics Sdn. Bhd. is a company in Malaysia, with a head office in Kuala Lumpur. The company operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. Agtc Genomics Sdn. Bhd. was incorporated on June 28, 2026. The company’s latest financial report indicates a net sales revenue increase of 56.62% in 2024. There was a total growth of 34% in Agtc Genomics Sdn. Bhd.’s total assets over the same period. The enterprise’s net profit margin increased by 4.99% in 2024.

Headquarters
J2-1 & J2-2, Pusat Perdagangan Bukit Jalil,, Jalan Persiaran Jalil, Bukit Jalil
Kuala Lumpur; Federal Territories; Postal Code: 57000

Contact Details: Purchase the Agtc Genomics Sdn. Bhd. report to view the information.

Basic Information
Financial Auditors:
Purchase the Agtc Genomics Sdn. Bhd. report to view the information.
Incorporation Date:
June 28, 2026
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Agtc Genomics Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
56.62%
Total Operating Revenue
56.62%
Operating Profit
237.36%
Net Profit/Loss for the Period
270.7%
Total Assets
34%
Total Equity
651.02%
Operating Profit Margin
6.7%
Net Profit Margin
4.99%
Return on Equity (ROE)
-8.92%
Quick Ratio
2.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?